164 related articles for article (PubMed ID: 12082618)
1. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.
Silva JM; Domínguez G; González-Sancho JM; García JM; Silva J; García-Andrade C; Navarro A; Muñoz A; Bonilla F
Oncogene; 2002 Jun; 21(27):4307-16. PubMed ID: 12082618
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
3. Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.
Li Z; Meng ZH; Chandrasekaran R; Kuo WL; Collins CC; Gray JW; Dairkee SH
Cancer Res; 2002 Apr; 62(7):1939-43. PubMed ID: 11929806
[TBL] [Abstract][Full Text] [Related]
4. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer.
Silva J; Domínguez G; Silva JM; García JM; Gallego I; Corbacho C; Provencio M; España P; Bonilla F
Oncogene; 2001 Jul; 20(33):4586-90. PubMed ID: 11494155
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of the ZBRK1 gene in human breast carcinomas.
Garcia V; Domínguez G; García JM; Silva J; Peña C; Silva JM; Carcereny E; Menendez J; España P; Bonilla F
J Pathol; 2004 Feb; 202(2):224-32. PubMed ID: 14743505
[TBL] [Abstract][Full Text] [Related]
7. Suppression of ING1 expression in sporadic breast cancer.
Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
[TBL] [Abstract][Full Text] [Related]
8. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
[TBL] [Abstract][Full Text] [Related]
9. Thyroid receptor: roles in cancer.
Aranda A; Martínez-Iglesias O; Ruiz-Llorente L; García-Carpizo V; Zambrano A
Trends Endocrinol Metab; 2009 Sep; 20(7):318-24. PubMed ID: 19716314
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone receptor and IGF1/IGFR systems: possible relations in the human heart.
Sabatino L; Gliozheni E; Molinaro S; Bonotti A; Azzolina S; Popoff G; Carpi A; Iervasi G
Biomed Pharmacother; 2007 Sep; 61(8):457-62. PubMed ID: 17560756
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues.
Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD
Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
15. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
16. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues.
Asch HL; Eliacin E; Fanning TG; Connolly JL; Bratthauer G; Asch BB
Oncol Res; 1996; 8(6):239-47. PubMed ID: 8895199
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
18. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
19. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
20. N-myc protein expression in human breast carcinoma: prognostic implications.
Mizukami Y; Nonomura A; Takizawa T; Noguchi M; Michigishi T; Nakamura S; Ishizaki T
Anticancer Res; 1995; 15(6B):2899-905. PubMed ID: 8669886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
